Open Menu Close Menu

WADA invites researchers, with expertise in the field of hematology, to apply for funding to undertake research projects aimed at delivering an anti-doping method that detects autologous blood transfusion (ABT). At a minimum, the method should: be applicable for blood and/or urine, be sensitive enough to detect ABT in a proportion of less than 150 mL (or 4%) of transfused, refrigerated or frozen, red blood cells (RBCs) with a window of detection of at least 24/36 hours; have a degree of specificity of 99.99% or above; and be transferrable to WADA-accredited laboratories for routine anti-doping testing.